洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR1900024658】Mechanisms involved in the effect of a brief mindfulness based intervention on personal recovery in people with bipolar disorder

基本信息
登记号

ChiCTR1900024658

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2019-07-20

临床申请受理号

/

靶点

/

适应症

bipolar disease

试验通俗题目

Mechanisms involved in the effect of a brief mindfulness based intervention on personal recovery in people with bipolar disorder

试验专业题目

Mechanisms involved in the effect of a brief mindfulness based intervention on personal recovery in people with bipolar disorder

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

0000

联系人通讯地址
临床试验信息
试验目的

1. To address extant research and intervention gaps by evaluating the efficacy and mechanisms of a psychosocial intervention to facilitate the process of personal recovery in adults living with BD; 2. To provide a novel insight into the landscape in which the brief MBI is applied to a new research area of personal recovery among people with BD; 3. To integrate the staging model of BD with the beneficial effects of the brief MBI along the process of personal recovery; 4. To better understand the lived experience of mindfulness during the personal recovery process among individuals living with BD; 5. To obtain important findings that will facilitate the development of our theoretical understanding of the change mechanisms important to the personal recovery process.

试验分类
试验类型

连续入组

试验分期

探索性研究/预试验

随机化

The PI will generate the random number sequence by a computer-generated randomization list.

盲法

Open label

试验项目经费来源

General Research Fund and Early Career Scheme

试验范围

/

目标入组人数

77

实际入组人数

/

第一例入组时间

2020-01-01

试验终止时间

2022-12-31

是否属于一致性

/

入选标准

1. A diagnosis of Bipolar I or II disorder; 2. In a state of full remission for more than two months; 3. On regular medication; 4. Aged 18 years old or above; 5. A Structured Clinical Interview for DSM-IV Disorders (SCID; only the mood disorders sections) will be administered by trained clinicians to confirm the diagnosis and remission status of the participants.;

排除标准

With active suicidal ideation or self-harm behaviours; People with a comorbid diagnosis of schizophrenia, schizoaffective disorder, substance misuse, organic brain syndrome, or intellectual disability will be excluded.;

研究者信息
研究负责人姓名
试验机构

Research Grants Council

研究负责人电话
研究负责人邮箱
研究负责人邮编

0000

联系人通讯地址
<END>

香港理工大學的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品